Market Overview

Benzinga's Top Pre-Market Gainers

Share:
Related MNKD
After SunEdison, Twitter Users See Valeant Filing Bankruptcy Next…Not SandRidge Or Another Solar Player
Why Goldman Is Still Selling Mannkind
Related BRCD
Wunderlich Downgrades Brocade, Spooked By Guidance Warning
Brocade Peers Largely Unaffected Following Q2 Warning
Brocade Reports Preliminary Fiscal Q— —…–6 Financial Results (GuruFocus)

MannKind (NASDAQ: MNKD) moved up 17.35% to $8.05 in the pre-market session after the company reported positive clinical data for AFREZZA.

Brocade Communications (NASDAQ: BRCD) soared 14.49% to $7.90 in the pre-market trading after the company reported better-than-expected fiscal third-quarter results.

Osiris Therapeutics (NASDAQ: OSIR) surged 9% to $27.73 in the pre-market session on clinical study results.

GenMark Diagnostics (NASDAQ: GNMK) shares gained 4.65% to $10.35 in the pre-market session after the company priced 7.6 million shares of common stock at $9.84.

Posted-In: Top Pre-Market GainersNews Pre-Market Outlook Markets Movers

 

Related Articles (BRCD + GNMK)

View Comments and Join the Discussion!